Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer.

Abstract

OBJECTIVE To evaluate the safety of fertility-sparing hormonal therapy for endometrial cancer in young patients. METHODS We reviewed the clinical and pathologic records of patients diagnosed with endometrial adenocarcinoma before the age of 40, who were treated and followed over a 30-year period in the Division of Gynecologic Oncology. All patients who… (More)

Topics

  • Presentations referencing similar topics